A Study on the Activation Peptide Released from Procarboxypeptidase B (CAPAP) and Anionic Trypsinogen in Patients with Acute Abdominal Disorders of Non-Pancreatic Origin

Publisher： Karger

E-ISSN： 1424-3911|3|2|149-155

ISSN： 1424-3903

Source： Pancreatology, Vol.3, Iss.2, 2003-05, pp. : 149-155

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cathepsin B Activates Human Trypsinogen 1 but Not Proelastase 2 or Procarboxypeptidase B

By  

Pancreatology, Vol. 6, Iss. 3, 2006-07 ,pp. : 224-231

Karger

Access to resources Recommend Favorite

Pre-Diagnostic Levels of Anionic Trypsinogen, Cationic Trypsinogen, and Pancreatic Secretory Trypsin Inhibitor in Relation to Pancreatic Cancer Risk

By  

Pancreatology, Vol. 10, Iss. 2-3, 2010-05 ,pp. : 229-237

Karger

Access to resources Recommend Favorite

Pancreatic fistulae secondary to trypsinogen activation by Pseudomonas aeruginosa infection after pancreatoduodenectomy

By  

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, Vol. 22, Iss. 6, 2015-06 ,pp. : 454-462

John Wiley & Sons Inc

Access to resources Recommend Favorite

Amrubicin Monotherapy for Patients with Platinum-Pretreated Non-Gastrointestinal Non-Pancreatic Extrapulmonary Neuroendocrine Carcinoma

By  

Oncology, Vol. 93, Iss. 3, 2017-05 ,pp. : 177-182

Karger

Access to resources Recommend Favorite

Trypsinogen-1, -2 and tumour-associated trypsin-inhibitor in bile and biliary tract tissues from patients with biliary tract diseases and pancreatic carcinomas

By Hedström J.   Haglund C.   Leinonen J.   Nordling S.   Stenman U.-H.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 61, Iss. 2, 2001-04 ,pp. : 111-118

Informa Healthcare

Access to resources Recommend Favorite